|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/36 | (2006.01) |
| A61P 31/04 | (2018.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61K 38/366 | (2013.01) |
| (11) | Number of the document | 3871684 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19875488.9 |
| Date of filing the European patent application | 2019-08-01 | |
| (97) | Date of publication of the European application | 2021-09-01 |
| (45) | Date of publication and mention of the grant of the patent | 2024-06-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2019/030133 |
| Date | 2019-08-01 |
| (87) | Number | WO 2020/084853 |
| Date | 2020-04-30 |
| (30) | Number | Date | Country code |
| 201862748706 P | 2018-10-22 | US | |
| 201862771628 P | 2018-11-27 | US | |
| 201962813352 P | 2019-03-04 | US |
| (72) |
MATSUKI Osamu , JP
TANAKA Kosuke , JP
TANAKA Risa , JP
|
| (73) |
Asahi Kasei Pharma Corporation ,
1-1-2 Yurakucho, Chiyoda-ku
Tokyo 100-0006,
JP
|
| (54) | DRUG FOR TREATING AND/OR IMPROVING SEPTICEMIA ASSOCIATED WITH COAGULATION ABNORMALITY |
| DRUG FOR TREATING AND/OR IMPROVING SEPTICEMIA ASSOCIATED WITH COAGULATION ABNORMALITY |